Literature DB >> 10817053

Ultrasound diagnosis of oesophagostomiasis.

P A Storey1, S Anemana, J A van Oostayen, A M Polderman, P Magnussen.   

Abstract

Human infection with Oesophagostomum bifurcum, a parasitic intestinal helminth, is endemic in parts of West Africa. Oesophagostomum bifurcum juveniles develop in the colonic wall, causing pus-filled granulomas. The pathology has two distinct forms. Multinodular oesophagostomiasis comprises hundreds of small nodules within a thickened, oedematous wall of the large intestine. Uninodular oesophagostomiasis, called the Dapaong tumour, presents as a painful 30-60 mm granulomatous mass in the abdominal wall or within the abdominal cavity. Diagnosis of oesophagostomiasis on clinical grounds alone is difficult. We describe cases illustrating the ultrasound appearance of these two presentations. Multinodular disease shows nodular "target" and "pseudokidney" colonic lesions. The Dapaong tumour is an echo-free ovoid lumen enveloped within a well defined poorly reflective wall.

Entities:  

Mesh:

Year:  2000        PMID: 10817053     DOI: 10.1259/bjr.73.867.10817053

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  3 in total

1.  Ultrasound appearance of preclinical Oesophagostomum bifurcum induced colonic pathology.

Authors:  P A Storey; G Faile; D Crawley; J A van Oostayen; S Anemana; A M Polderman; P Magnussen
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Nodular Worm Infections in Wild Non-human Primates and Humans Living in the Sebitoli Area (Kibale National Park, Uganda): Do High Spatial Proximity Favor Zoonotic Transmission?

Authors:  Marie Cibot; Jacques Guillot; Sophie Lafosse; Céline Bon; Andrew Seguya; Sabrina Krief
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09

3.  The Conqueror Worm: recent advances with cholinergic anthelmintics and techniques excite research for better therapeutic drugs.

Authors:  R J Martin; S Puttachary; S K Buxton; S Verma; A P Robertson
Journal:  J Helminthol       Date:  2014-05-29       Impact factor: 2.170

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.